Allogene Therapeutics, Inc. (ALLO)
2.08
+0.03
(+1.46%)
USD |
NASDAQ |
Feb 23, 16:00
2.10
+0.02
(+0.96%)
After-Hours: 19:59
Allogene Therapeutics Market Cap : 467.44M for Feb. 23, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 110.59M |
| Curis, Inc. | 14.22M |
| LadRx Corp. | 0.015M |
| Plus Therapeutics, Inc. | 37.46M |
| Windtree Therapeutics, Inc. | 0.3721M |
Market Cap Related Metrics
| Price to Book Value | 1.482 |
| Price | 2.08 |
| Earnings Yield | -47.17% |